Point32Health challenges Aduhelm, threatens coverage for 1.1M members
(By Nick Moran for Becker’s Hospital Review) Point32Health may not cover Biogen’s new Alzheimer’s treatment, Aduhelm, for its commercial members unless
Read More
Part D/Prescription Drugs
A crucial, overlooked question on the new Alzheimer’s drug: When should patients stop taking it?
(By Megan Molteni for STAT) For families and physicians grappling with the historic approval this month of the controversial Alzheimer’s
Read More5 BCBS plans back pharmacy startup
(By Nick Moran for Becker’s Hospital Review) Five Blue Cross Blue Shield plans are funding and collaborating with Evio, a
Read MoreDrug-resistant bacteria pose a growing threat. Can new antibiotics be developed fast enough to combat them?
(By Ed Silverman for STAT) In 2016, a landmark report was issued on the global problem of antimicrobial resistance. The paper,
Read MoreAduhelm could soon represent 1% of all US healthcare spending
(By Katie Adams for Becker’s Hospital Review) Biogen’s Alzeheimer’s drug Aduhelm could single-handedly represent 1 percent of all national healthcare
Read MoreBrain cancer drug Gleostine pulled from Medicare Part D
(By Lauren Jensik for Becker’s Hospital Review) Brain cancer drug Gleostine is no longer available for coverage under Medicare Part
Read MoreMedicare’s spending on ‘ultra-expensive’ drugs increased by 1,170% in 6 years Katie Adams – 19 hours ago Print | Email
(By Katie Adams for Becker’s Hospital Review) As more drugs enter the market with five-figure annual list prices, a large
Read MoreWhat is the Medicare star rating system?
Medicare’s Open Enrollment starts October 15th, but it’s not too early to think about your Medicare coverage. During open enrollment,
Read MoreQ&A: The CEO of the Alzheimer’s Association on the approval of Aduhelm — and why critics should stop dwelling on the decision
(By Andrew Joseph for STAT) Harry Johns is ready to stop talking about whether or not the Food and Drug
Read MoreMost pharmaceuticals and protective personal equipment are manufactured outside the United States.
The COVID-19 pandemic has revealed a host of problems; among them was the realization that most pharmaceuticals are manufactured outside
Read More